Sort
21,281 grants matching “influenza”
Effects of microbial exposure on TB pathogenesis
$192,500Elise Lamont · University Of Minnesota · R21 · FY2025 · AI
Erythroid cell modulation of T cell function
$192,500Elizabeth A Bonney · University Of Vermont & St Agric College · R21 · FY2016 · AI
Mechanisms of non-neutralizing antibody-mediated protection from influenza virus
$192,500Denise A Kaminski · University Of Rochester · R21 · FY2009 · AI
Investigating the human spleen as an archive of memory B cells reactive to the influenza virus hemagglutinin
$192,500Mark Y Sangster · University Of Rochester · R21 · FY2025 · AI
Lambda phage as a scaffold for influenza immunization
$192,500Stephen Dewhurst · University Of Rochester · R21 · FY2007 · AI
Role of early life hyperoxia on mesenchymal stem cell fate: their impact on age related disease
$192,500Michael A O'Reilly · University Of Rochester · R21 · FY2022 · AG
Visualizing the resolution of innate immune responses during influenza infection
$192,500Minsoo Kim · University Of Rochester · R21 · FY2021 · AI
MECHANISMS REGULATING AVIAN INFLUENZA VIRUS INFECTIONS IN HUMANS
$192,433Richard John Webby · St. Jude Children'S Research Hospital · R01 · FY2020 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$192,338Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2021 · AI
Treatments for Benign Paroxysmal Positional Vertigo
$192,255Helen S Cohen · Baylor College Of Medicine · R01 · FY2008 · DC
Peru Infectious Diseases Epidemiology Research Training Consortium
$192,240Andres G Lescano · Naval Medical Research Unit South (Namru South) · D43 · FY2010 · TW
Lung and bone marrow crosstalk during a respiratory infection
$192,240Carolina B. Lopez · University Of Pennsylvania · R21 · FY2010 · AI
Generation of a polycistronic universal influenza virus vaccine based on rare species adenoviral vectors
$192,153Lynda Coughlan · University Of Maryland Baltimore · R21 · FY2020 · AI
INFLAMMATORY MECHANISMS IN VIRAL OTITIS MEDIA
$192,114University Of North Carolina Chapel Hill · K23 · FY2002 · DC
Identifying host factors and the mechanisms used to control influenza virus replication
$192,095Andrew Mehle · University Of Wisconsin-Madison · R21 · FY2017 · AI
Effective Mucosal Vaccination through Engineered Outer Membrane Vesicles
$192,080David A Putnam · Cornell University · R21 · FY2018 · AI
Design of immunologically intact soluble HCV E1E2 complexes using transmembrane-mimic scaffolds
$191,930Brian G. Pierce · Univ Of Maryland, College Park · R21 · FY2020 · AI
The Affordable Care Act: MCV/PCV & Pertussis
$191,878Ken A. Gershman · Colorado State Dept/Pub Hlth & Environmt · U01 · FY2011 · CI
Asymmetric Synthesis of Bioactive Natural Products Using Nazarov Cyclization
$191,875Alison J Frontier · University Of Rochester · R01 · FY2012 · GM
Influenza vaccine immunity shaped by human-like influenza epitopes
$191,875Anne Searls De Groot · University Of Rhode Island · R21 · FY2018 · AI
B Cell Development in Aging
$191,875John C. Cambier · University Of Colorado Denver · R21 · FY2009 · AI
B cell presentation of antigen to CD4 T follicular helper cells
$191,875Andrea Janine Sant · University Of Rochester · R21 · FY2013 · AI
Novel Cellular Factors Restricting Viral Membrane Fusion
$191,875Shan-Lu Liu · University Of Missouri-Columbia · R21 · FY2014 · AI
Enhanced Live Attenuated Influenza Virus With Improved Safety and Immunogenicity
$191,875Stephen Dewhurst · University Of Rochester · R21 · FY2014 · AI
Naturally Occurring Lipid Mediators Enhance Antibody Production
$191,875Richard P. Phipps · University Of Rochester · R21 · FY2014 · AI